StonvexLoading…
StonvexStonvexStonvexCore line items from BLSH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $244.81B | $250.20B | $116.49B |
Operating Income | $-786.41M | $84.57M | $1.30B |
Net Income | $-785.47M | $79.56M | $1.30B |
EPS (Diluted) | $-5.99 | $0.68 | $10.63 |
Total Assets | $3.96B | $3.05B | Not available |
Total Liabilities | $658.17M | $646.75M | Not available |
Cash & Equivalents | $87.89M | $31.54M | $112.90M |
Free Cash Flow OCF − CapEx | $18.70M | $-30.37M | $-127.63M |
Shares Outstanding | Not available | Not available | Not available |